Skip to main content
Search
Cures
Roadmap to Cures
Where We’ve Been
Roadmap 1.0
Delivery
Viral
Non-Viral
Small RNA
Cargo
Gene Therapy
Base Editing
Prime Editing
MECP2 Reactivation
RNA Editing
RNA Trans-splicing
Tracking
Rett Syndrome Global Registry
Citizen Health
Biomarkers
Biosensors
VIBRANT
Families
Was your child
recently diagnosed?
We’re here for you.
Reach Out Now
Recently Diagnosed
For All Families
About Rett Syndrome
Genetics Primer
Rett Syndrome Global Registry
Rett Clinics & Clinical Trials
Thriving with Rett Guides
Rett Fact Cards
Researchers
Fundraise
Start Your Own
Crowdfunding Page
We’ll get you set up!
Get Started
Get Started Now
Join Us
Events
RettGive Campaigns
Facebook Fundraisers
Donate
About Us
News
Get timely, factual news about Rett syndrome.
Browse News
Articles
Research
Community
Fundraising
Press Releases
Rett in the News
Donate
Join Us
Donate
Join Us
Cures
Roadmap to Cures
Where We’ve Been
Roadmap 1.0
Delivery
Viral
Non-Viral
Small RNA
Cargo
Gene Therapy
Base Editing
Prime Editing
MECP2 Reactivation
RNA Editing
RNA Trans-splicing
Tracking
Rett Syndrome Global Registry
Citizen Health
Biomarkers
Biosensors
VIBRANT
Families
Recently Diagnosed
For All Families
About Rett Syndrome
Genetics Primer
Rett Syndrome Global Registry
Rett Clinics & Clinical Trials
Thriving with Rett Guides
Rett Fact Cards
Researchers
Fundraise
Get Started Now
Join Us
Events
RettGive Campaigns
Facebook Fundraisers
Donate
About Us
News
Articles
Research
Community
Fundraising
Press Releases
Rett in the News
Rett Syndrome Global Registry
RettGive
Search
Research
June 18, 2021
Developing an Epigenetic Therapeutic for MECP2 Reactivation
June 6, 2021
New Collaboration Intensifies Effort to Cure Rett Syndrome by Reactivating MECP2
June 3, 2021
In their own words - members of RSRT’s newly formed Translational Medicine Advisory Board share their reasons for optimism
May 26, 2021
Seven New RSRT-Supported Therapeutics Make Their Way Towards Clinical Trials
May 12, 2021
Introducing ACTX 101, a Gene Therapy for Rett Using X Reactivation Technology
April 26, 2021
Assessing Rett Symptoms with Cutting Edge Biosensors and Invisible Technology
March 27, 2021
Taysha Gene Therapies Statement on Covid-19 Vaccines
February 16, 2021
DNA Editing as a Therapeutic Modality for Rett Syndrome
February 9, 2021
Novartis OAV201 Update
December 16, 2020
Developing A NextGen RNA Therapy for Rett Syndrome
October 7, 2020
Community Update: Progress To A Cure
September 9, 2020
The Next Phase of Our Attack on Rett: CURE 360
August 21, 2020
AveXis/Novartis Statement on AVXS-201
June 28, 2020
Enhancing the Potential Impact of Gene Therapy
May 6, 2020
Mutations Fighting Mutations
April 17, 2020
The Power of Three
April 2, 2020
Rett Research in a Time of Crisis
February 25, 2020
Biomarkers - What are they and why do we need them?
1
…
4
5
6
7
8
…
15
$
40M
Take Action